Navigation Links
The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
Date:12/13/2011

PARIS, December 13, 2011 /PRNewswire/ --

- The Pharmabiotic Research Institute (PRI) brings together industrial and academic players in the area of probiotics research. It is a unique scientific and regulatory association in Europe.

- The PRI asserts that, beyond their traditional food processing applications, probiotics can also be active pharmacological constituents with preventive and curative potential. This is why PRI uses the terminology "Pharmabiotics", relating to "LBP - Live Biotherapeutic Products" rather than "Probiotics".

- In 2012, the PRI will publish its first works, underway since 2009 through various working groups relating to the adaptation of the general directives provided by the CTD format (Common Technical Document - used for the qualification of drugs) to the specificities of Pharmabiotics.

- The PRI initiative echoes the ever increasing number of scientific publications (more than 100 per month on average), of which the proof of concept attests to a scientific consensus emerging around the therapeutic potential of probiotics.

THE PRI: a French association which has become a single European structure, a federation of more than 40 members throughout Europe

- The PRI is a federation of groups with both academic and industrial competences, working for the development of probiotics, from the fundamental research to the industrial production of the end product.

- Created at the end of 2009 in Aurillac, it is chaired by Professor Michel Dapoigny, gastroenterologist at the University Hospital of Clermont-Ferrand.

- The PRI today counts 42 federated members coming from the pharmaceutical industry, the university world and research. Nevertheless, the number of members continues to increase. As a whole, the members, whose competences include research in microbiology and/or pharmacological development, are involved in research, development, production and the marketing of probiotics.

- Lab
'/>"/>

SOURCE The Pharmabiotic Research Institute (PRI)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Researchers realize high-power, narrowband terahertz source at room temperature
2. MU researchers identify key plant immune response in fight against bacteria
3. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
4. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
5. Software Helps Research Facilities Meet New NIH Financial Conflict of Interest (FCOI) Requirements
6. Liquid, Ammonium Ion-Free Glutathione Reductase Enzyme Introduced by Bio-Research Products
7. Researchers develop one of the worlds smallest electronic circuits
8. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
9. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
10. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
11. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Students and faculty from ... first half of “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty members ... course combines students from both universities and is taught on both continents. , ...
(Date:6/30/2015)... , June 30, 2015  NASA astronaut Kjell ... next month on his first mission to the International ... from 8 to 9 a.m. EDT Tuesday, July 7. ... in Star City, Russia . The interviews ... NASA Television highlighting his mission training. To schedule ...
(Date:6/30/2015)... ... 30, 2015 , ... uBiome and OpenBiome Partner for Microbiome ... fecal microbiota transplantation in C. difficile patients. , SAN FRANCISCO, uBiome and OpenBiome ... microbiota transplantation (FMT) as a treatment for Clostridium difficile infections (C. diff). , ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares ... outstanding common shares (including shares of unvested restricted stock). On June 29, 2015, the ... price of Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , The ...
Breaking Biology Technology:Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3
... Sagent Pharmaceuticals, Inc.,a privately-held specialty pharmaceutical company, today ... Red Cross to assist the victims,of Monday,s earthquake ... the global community, we were saddened by the ... said Jeffrey M. Yordon,chief executive officer, founder, and ...
... NANJING, China, May 14 Simcere Pharmaceutical,Group (NYSE: SCR ... manufacturer of the patented anti-cancer biotech,product Endu in China, today ... investor conferences:, * Brean Murray Carret & ... Waldorf-Astoria in New York on Monday, May 19, 2008 ...
... 1c Study Demonstrates Dose-dependent Activity of Antidote Component, ... today announced,the Journal of Thrombosis and Haemostasis, the ... Haemostasis, has published the,Phase 1c clinical results of ... system comprised of an aptamer-based anticoagulant,RB006, and its ...
Cached Biology Technology:Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York 2Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis 2Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis 3Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis 4
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces that its ... segment on "Money on the Mark", scheduled to air on ... June 20 th . The broadcast ... from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino ...
(Date:6/16/2015)... /CNW Telbec/ - handyem Inc. and FlowMetric Diagnostics ... of handyem,s HPC-150 portable flow cytometer within FlowMetric ... unprecedented model of mobile laboratory platform is presented ... Pennsylvania Convention Center, ... to 18 th 2015.  By virtue of ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3
... JUPITER, FL, April 10, 2010 For years, scientists ... of producing specific proteins through RNA transcription. Now, research led ... Institute has shown DNA can also act to fine-tune the ... These new findings may make it possible to design therapies ...
... roughly six million Americans, yet treatment consists of either a ... the heart. This is unacceptable to Roberto Bolli, MD, Chief ... Louisville in Louisville, Ky., which is why he is on ... for all who must cope with the limitations of a ...
... falls in a virtual reality forest, will anyone hear an environmental ... who cut down the make-believe redwood. New findings from Stanford ... forest and told to saw through a towering sequoia until it ... real world than people who only imagined what it,s like to ...
Cached Biology News:Scripps Research scientists uncover new DNA role in modifying gene function 2Scripps Research scientists uncover new DNA role in modifying gene function 3Roberto Bolli discusses cardiac stem cell treatment for heart failure at Cannon Lecture 2Roberto Bolli discusses cardiac stem cell treatment for heart failure at Cannon Lecture 3Stanford's virtual reality lab focuses on conservation 2Stanford's virtual reality lab focuses on conservation 3